Cite
Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies
MLA
Sanne J. M. Hoefnagel, et al. “Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies.” Cancers, vol. 14, no. 18, Sept. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3a6ef8022537b34ad33987ed64a8c33&authtype=sso&custid=ns315887.
APA
Sanne J. M. Hoefnagel, Willem J. Koemans, Hina N. Khan, Jan Koster, Sybren L. Meijer, Jolanda M. van Dieren, Liudmila L. Kodach, Johanna W. van Sandick, Silvia Calpe, Carmen M. del Sancho-Serra, Ana C. P. Correia, Mark I. Van Berge Henegouwen, Suzanne S. Gisbertz, Maarten C. C. M. Hulshof, Sandro Mattioli, Manon C. W. Spaander, & Kausilia K. Krishnadath. (2022). Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies. Cancers, 14(18).
Chicago
Sanne J. M. Hoefnagel, Willem J. Koemans, Hina N. Khan, Jan Koster, Sybren L. Meijer, Jolanda M. van Dieren, Liudmila L. Kodach, et al. 2022. “Identification of Novel Molecular Subgroups in Esophageal Adenocarcinoma to Predict Response to Neo-Adjuvant Therapies.” Cancers 14 (18). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f3a6ef8022537b34ad33987ed64a8c33&authtype=sso&custid=ns315887.